Teva and Mylan implore Fed Circuit not to stay immunity ruling
07-11-2018
Allergan and tribe ask for stay pending SCOTUS appeal
29-10-2018
07-03-2019
sruilk / Shutterstock.com
The US Court of Appeals for the Federal Circuit yesterday, March 6, refused to rehear a decision which found Allergan and the Saint Regis Mohawk Tribe’s patents for dry-eye treatment Restasis (cyclosporine ophthalmic emulsion) are invalid.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Allergan, Saint Regis Mohawk Tribe, en banc, Restasis, patent, tribal immunity, US Supreme Court, inter partes reviews, IPRs